scholarly article | Q13442814 |
P50 | author | Estelle Jumas-Bilak | Q107216363 |
P2093 | author name string | Patrick Chardon | |
Hélène Jean-Pierre | |||
Sylvie Parer | |||
Anne Lotthé | |||
Rosie Poncet | |||
P2860 | cites work | Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications | Q24646677 |
Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus | Q28362193 | ||
Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature | Q31105046 | ||
Vancomycin-intermediate and -resistant Staphylococcus aureus: what the infectious disease specialist needs to know | Q31704853 | ||
Molecular evidence that nasal carriage of Staphylococcus aureus plays a role in respiratory tract infections of critically ill patients | Q33885105 | ||
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). | Q34691938 | ||
Highly effective regimen for decolonization of methicillin-resistant Staphylococcus aureus carriers | Q34782459 | ||
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
Staphylococcus aureus throat colonization is more frequent than colonization in the anterior nares | Q35073211 | ||
Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods | Q35541702 | ||
Prevalence and characteristics of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia in a tertiary care center | Q35784453 | ||
Impact of reduced vancomycin susceptibility on the therapeutic outcome of MRSA bloodstream infections. | Q36287998 | ||
Emergence of vancomycin resistance during therapy against methicillin-resistant Staphylococcus aureus in a burn patient—importance of low-level resistance to vancomycin | Q44420121 | ||
Control and outcome of a large outbreak of colonization and infection with glycopeptide-intermediate Staphylococcus aureus in an intensive care unit | Q44589914 | ||
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals | Q44868572 | ||
Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination | Q44895623 | ||
Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin | Q45199316 | ||
Methicillin-resistant Staphylococcus aureus disease in three communities | Q46426018 | ||
Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin-resistant Staphylococcus aureus outbreak on a surgical ward | Q46810443 | ||
A simultaneous outbreak on a neonatal unit of two strains of multiply antibiotic resistant Klebsiella pneumoniae controllable only by ward closure. | Q53882709 | ||
Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. | Q54070345 | ||
Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. | Q55067143 | ||
An Outbreak of Staphylococcus aureus Strains with Reduced Susceptibility to Glycopeptides in a French General Hospital | Q58442608 | ||
P433 | issue | 2 | |
P921 | main subject | Staphylococcus aureus | Q188121 |
intensive care unit | Q5094647 | ||
P304 | page(s) | 167-174 | |
P577 | publication date | 2012-01-03 | |
P1433 | published in | Infection Control and Hospital Epidemiology | Q6029185 |
P1476 | title | An outbreak of heterogeneous glycopeptide-intermediate Staphylococcus aureus related to a device source in an intensive care unit. | |
P478 | volume | 33 |
Q35067853 | A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012. |
Q38023077 | Computational analysis of interactomes: current and future perspectives for bioinformatics approaches to model the host-pathogen interaction space. |
Q35999912 | Evolving resistance among Gram-positive pathogens |
Q98164449 | Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical isolates: a systematic review and meta-analysis |
Q36056758 | Importance of Multifaceted Approaches in Infection Control: A Practical Experience from an Outbreak Investigation |
Q38171759 | Methicillin-resistant Staphylococcus aureus: an evolving pathogen |
Q34259874 | Methicillin-sensitive Staphylococcus aureus CC398 in intensive care unit, France |
Q26796560 | Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates |
Search more.